Skip to main content

Muscle Soreness

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
Diclofenac sodium gel 1%Phase 31 trial
Active Trials
NCT02271854Completed102Est. Dec 2014
Lonza
LonzaBasel, Switzerland
1 program
CarnipureN/A1 trial
Active Trials
NCT04420377Completed82Est. Jun 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SandozDiclofenac sodium gel 1%
LonzaCarnipure

Clinical Trials (2)

Total enrollment: 184 patients across 2 trials

NCT02271854SandozDiclofenac sodium gel 1%

A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness

Start: Oct 2014Est. completion: Dec 2014102 patients
Phase 3Completed

The Chronic Effects of Carnitine on Recovery

Start: Mar 2020Est. completion: Jun 202082 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.